Severe thrombocytopenia during Natalizumab therapy: A case report

J Neurol Sci. 2020 Feb 15:409:116587. doi: 10.1016/j.jns.2019.116587. Epub 2019 Nov 22.
No abstract available

Keywords: Multiple sclerosis; Natalizumab; Purpura; Thrombocytopenia.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Humans
  • Immunologic Factors / adverse effects*
  • Male
  • Multiple Sclerosis, Relapsing-Remitting / diagnosis
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy
  • Natalizumab / adverse effects*
  • Severity of Illness Index*
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / diagnosis*

Substances

  • Immunologic Factors
  • Natalizumab